NLRP3 and atherosclerosis: In vivo and in vitro experiments have demonstrated that IL-36α promotes the NLRP3 expression and activation in mouse renal tubular epithelial cells and macrophages (44), while IL-36Ra inhibits NLRP3 activation and reduces inflammation in a mouse model of atherosclerosis (45).